European Companies Search Engine
EU funding (€899,963): Springboard for excellence in advanced development of antibacterials Hor19 Jun 2020 EU Research and Innovation programme "Horizon"
Overview
Text
Springboard for excellence in advanced development of antibacterials
The main goal of SPRINGBOARD project is to strengthen research potential of the Latvian Institute of Organic Synthesis (LIOS) through establishing long-lasting and sustainable collaboration network with the leading European research institutions – University of Antwerp, University of Copenhagen, University of Florence and University of Helsinki – in the area of advanced discovery and design of novel antibacterial drugs. An increased competence of LIOS staff (especially early stage researchers) on identification of new enzymatic targets, application of natural products and their synthetic analogues, biopharmaceuticals, antisense and peptide antibiotics as antibacterials, as well as experience on biofilm formation and quorum sensing molecules as targets for new antibacterial therapies will be achieved as a result. The implementation of SPRINGBOARD will ensure the establishment of platform of excellence in this area through: •exchange of the best practice via staff exchange and expert visits; •increase capacity building of early stage researchers; •improvement of research management and administration skills; •organization of joint events; •building capacity for participation in competitive joint proposals of projects for Horizon Europe and other relevant programmes; •dissemination, communication and outreach activities. This collaboration will ensure: •full exploitation of research and innovation capacity of LIOS; •rise of LIOS staff research profiles focusing on early stage researchers; •increase in LIOS visibility and integration in ERA; •contribution to actual socio-economic challenge in connection to widespread infectious diseases; •public awareness on the importance of development of new antibacterial drugs. SPRINGBOARD will contribute to the Responsible Research and Innovation approach that will support creation and interdisciplinary collaboration as well as knowledge exchange to improve public health and quality of life.
Funded Companies:
| Company name | Funding amount |
| HELSINGIN YLIOPISTO | €101,775 |
| Kobenhavns Universitet | €116,563 |
| Latvijas Organiskas Sintezes Instituts | €466,250 |
| Universita Degli Studi Di Firenze | €95,125 |
| Universiteit Antwerpen | €120,250 |
Source: https://cordis.europa.eu/project/id/951883
The filing refers to a past date, and does not necessarily reflect the current state.
The visualizations for "HELSINGIN YLIOPISTO - EU funding (€899,963): Springboard for excellence in advanced development of antibacterials"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.
